Where we are now in PDAC care: Clinical insights, emerging biomarkers and evolving therapeutic strategies

touchEXPERT FOCUS for touchNEUROLOGY, touchIMMUNOLOGY, touchOPHTHALMOLOGY    Dr. Eoin Flanagan shares his expert insights on myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and how to distinguish it from other demyelinating diseases like multiple sclerosis (MS) and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-positive NMOSD). As part of the interview, Dr. Flanagan describes MOGAD’s pathogenesis and explains how to achieve an early accurate diagnosis using the latest diagnostic frameworks.   The expert Dr. Eoin Flanagan, Mayo Clinic, Rochester, MN, USA   This activity is funded by an independent medical education grant from UCB. It is jointly provided by USF Health and touchIME.   This touchPODCAST is for healthcare professionals in the USA only.   For further information, please visit our websites: www.touchNEUROLOGY.com, www.touchIMMUNOLOGY.com, www.touchOPHTHALMOLOGY.com

touchMDT for touchIMMUNOLOGY, touchHEMATOLOGY, touchDERMATOLOGY, and touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the diagnosis, classification, and management of patients with systemic mastocytosis. They provide their key insights on effectively recognizing systemic mastocytosis, integrating key classification criteria from the ICC and WHO, and how multidisciplinary care is needed to effectively manage patients with systemic mastocytosis.   The multidisciplinary team Allergist/Immunologist: Dr. Cem Akin, University of Michigan Health, Ann Arbor, MI, USA Allergist/Immunologist: Dr. Theo Gülen, Karolinska University Hospital, Stockholm, Sweden Hematologist: Dr. Tsewang Tashi, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an unrestricted independent medical education grant from BluePrint Medicines Corporation.  This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchHEMATOLOGY.com, www.touchIMMUNOLOGY.com, www.touchDERMA.com, or www.touchONCOLOGY.com

touchMDT for touchIMMUNOLOGY, touchHEMATOLOGY, touchDERMATOLOGY, and touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the diagnosis, classification, and management of patients with systemic mastocytosis. They provide their key insights on effectively recognizing systemic mastocytosis, integrating key classification criteria from the ICC and WHO, and how multidisciplinary care is needed to effectively manage patients with systemic mastocytosis.   The multidisciplinary team Allergist/Immunologist: Dr. Cem Akin, University of Michigan Health, Ann Arbor, MI, USA Allergist/Immunologist: Dr. Theo Gülen, Karolinska University Hospital, Stockholm, Sweden Hematologist: Dr. Tsewang Tashi, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an unrestricted independent medical education grant from BluePrint Medicines Corporation.  This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchHEMATOLOGY.com, www.touchIMMUNOLOGY.com, www.touchDERMA.com, or www.touchONCOLOGY.com

touchMDT for touchIMMUNOLOGY, touchHEMATOLOGY, touchDERMATOLOGY, and touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the diagnosis, classification, and management of patients with systemic mastocytosis. They provide their key insights on effectively recognizing systemic mastocytosis, integrating key classification criteria from the ICC and WHO, and how multidisciplinary care is needed to effectively manage patients with systemic mastocytosis.   The multidisciplinary team Allergist/Immunologist: Dr. Cem Akin, University of Michigan Health, Ann Arbor, MI, USA Dermatologist: Dr. Lauren Madigan, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an unrestricted independent medical education grant from BluePrint Medicines Corporation.  This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchHEMATOLOGY.com, www.touchIMMUNOLOGY.com, www.touchDERMA.com, or www.touchONCOLOGY.com

touchEXPERT FOCUS for touchONCOLOGY Listen to an interview with Dr. Deborah Wong as she shares her expert insights on the current evidence and latest guidelines for immune checkpoint inhibitor (ICIs) use in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC). She also discusses how patient- and disease-specific factors can inform individualized treatment decisions. The expert: Dr. Deborah Wong, University of California, Los Angeles (UCLA), CA, USA   This activity is funded by an independent medical education grant from Coherus Oncology, Inc. This activity is jointly provided by USF Health and touchIME. This touchPODCAST is for HCPs in the USA only.   For further information, please visit our website: www.touchONCOLOGY.com  

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of short interviews with three leading experts discussing chronic and/or recurrent postoperative intraocular inflammation. The faculty explore how to identify patients with persistent disease, differentiate infectious, mechanical, and non-infectious etiologies, and use multimodal imaging to evaluate underlying causes and posterior segment involvement. They also discuss how diagnostic findings guide treatment decisions, when to reassess or escalate management, and practical approaches to achieving durable disease control through individualized, etiology-driven treatment strategies. The experts: Dr. Aniruddha Agarwal—Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates Prof. Marion Munk—Augenarzt-Praxisgemeinschaft Gutblick AG, Pfäffikon, Switzerland; University Hospital Bern, Switzerland; Northwestern University, Chicago, IL, USA Prof. Francesco Bandello—University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy This touchPODCAST is for healthcare professionals outside of the UK and USA. This activity is supported by an independent medical education grant from Alimera Sciences Europe Ltd. This activity is jointly provided by Partners for Advancing Clinical Education and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: touchophthalmologyime.org

touchCONGRESS for touchONCOLOGY and touchRESPIRATORY   Listen to thoracic oncologist Dr. Julia Rotow (USA) review the latest HER2-targeted therapy data for NSCLC from the 2026 ASCO Annual Meeting. Alongside Prof. David Planchard (France) and Dr. Misako Nagasaka (USA), they discuss these findings in the context of evidence presented at recent international congresses and their clinical implications for managing HER2-altered NSCLC. The experts Dr. Julia Rotow, Dana-Farber Cancer Institute, Boston, MA, USA Prof. David Planchard, Institut Gustave Roussy, Paris, France Dr. Misako Nagasaka, University of California, Irvine (UCI) Health Chao Family Comprehensive Cancer Center, Orange, CA, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from AstraZeneca.  This activity is jointly provided by USF Health and touchIME.  touchIME is an EBAC® accredited provider. For further information, visit our website: www.touchoncology.com or www.touchrespiratory.com

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss how biomarker-driven insights and emerging therapies are shaping treatment decisions in PDAC. They cover early testing strategies, novel targeted and immunologic therapies, and evidence-based treatment sequencing across the disease continuum. The experts: Dr. Allyson Ocean - Weill Cornell Medicine, New York, NY, USA Prof. Thierry Conroy - Institut de Cancérologie de Lorraine, University of Lorraine Nancy, France Dr. Eileen O'Reilly - Memorial Sloan Kettering Cancer Center, New York NY, United States This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Revolution Medicines. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchONCOLOGY.com

touchPANEL DISCUSSION for touchNEUROLOGY Listen to three leading experts discussing the recent advances in timely, biomarker-guided diagnosis and how current and emerging intravenous and subcutaneous disease-modifying therapies may impact clinical practice in the future and enable treatment personalization based on the underlying pathology of Alzheimer’s disease The experts Dr Soo Borson, Keck USC School of Medicine, Los Angeles, CA, USA Dr Clifford Singer, Northern Light Acadia Hospital, Bangor, ME, USA Dr Frederick Ketchum, University of Wisconsin-Madison, Madison, WI, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Eisai Inc. Jointly provided by Partners for Advancing Clinical Education and touchIME in collaboration with the Gerontological Society of America (GSA). For further information, visit:  www.touchNEUROLOGY.com

touchIN CONVERSATION for touchOPHTHALMOLOGY As treatment options for geographic atrophy continue to evolve, clinicians face new opportunities and challenges in diagnosis, treatment planning, and patient engagement. Join retina specialists Dr. Samuel Minaker and Dr. Priya Vakharia for a peer-to-peer discussion on geographic atrophy care, covering the patient journey from diagnosis to effective patient management and communication. The experts Dr. Samuel Minaker, Tyler Retina Consultants, Tyler, TX, USA Dr. Priya Vakharia, Retina Vitreous Associates of Florida, Tampa, FL, USA This touchPODCAST is for HCPs in the USA only. This activity is supported by an independent medical education grant from Apellis, a Subsidiary of Biogen.  Jointly provided by Partners for Advancing Clinical Education and touchIME. For further information visit our website: www.touchOPHTHALMOLOGY.com